Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by MustangSalleyon Jul 29, 2021 6:13pm
102 Views
Post# 33629757

RE:RE:RE:wannabe

RE:RE:RE:wannabe

Moneymouth ,

The only thing they did this year was hire Frank Shannon and a poor financing . All the other stuff collaborations , study have been ongoing for years . Same with Thyroid and Wiseman .

They have increased the float by a factor of almost 200 million shares .  They ran away and did not address any of the investors during the AGM. Gave themselves 15% option and bonus plan , lost two key employees and we have not seen anything from any secret NDA collaboration for over 10 years .

Too bad you did not buy for 5 cents or 25 cents that some of the investors had in the past 11 years . Trust me MM , if there is enough liquidity , there are about 100 million shares looking to exit .  So tell me why the share price is going down to $1.20 then ?


Ms Sally 

<< Previous
Bullboard Posts
Next >>